Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT06570070
Active, not recruiting Not applicable

AI-powered Smoking Cessation Intervention

NCT06570070 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Normal University
Phase
Not applicable
Started
2025-01-22
Last updated
2026-09-09

Condition(s) studied

Smoking CessationMobile Health

Investigational drug(s) / intervention(s)

5A's/5R's adviceBrief leaflet on health warning and smoking cessationSelf-help smoking cessation bookletAI-powered chatbot supportCounselor individual support

5A's/5R's advice: 5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit.

Brief leaflet on health warning and smoking cessation: The contents of the leaflet include the absolute risk of smoking, diseases caused by active and second-hand smoking, horrible pictorial warnings of the health consequences of active and second-hand smoking, and the benefits of quitting.

Self-help smoking cessation booklet: The contents include information about the benefits of quitting, methods to quit, how to handle withdrawal symptoms, misperceptions of quitting, etc.

AI-powered chatbot support: Participants will receive three months of AI-powered chatbot, equipped with personalized interactions and real-time support, via WeChat.

Counselor individual support: Participants will receive three months of counselor-led individual support via WeChat. The regular messages and instant messaging on psychosocial support aim to provide cessation advice, increase self-efficacy and confidence, and social support and behavioral capacity of quitting.

Study summary

This study aims to explore the feasibility and effectiveness of AI-powered chatbot support in community smokers.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. aged 18 and above, reside in Zhuhai for the next 6 months; 2. smoke at least 1 cigarette or use e-cigarettes daily; 3. Having a smartphone and a WeChat account, being able to use WeChat skillfully. Exclusion Criteria: 1. Smokers who have communication barrier (either physically or cognitively); 2. Smokers who are currently participating in other SC programmes or services

Primary outcome measure(s)

  • Biochemical validated quit rate at 6 months follow-up — 6 months follow-up
    The primary outcomes are biochemically validated quit rate (exhaled carbon monoxide \< 4 ppm or salivary cotinine \< 30 ng/ml)

Trial sites (1)

FacilityCityRegionStatus
Beijing Normal University Zhuhai Guangdong

More Beijing Normal University trials in China

Cognitive and Emotional Inoculation Against Nutrition-Related Misinformation in Young Adults Starting soon
Metaphor-Based Smoking Cessation Intervention Starting soon
Evidence-Based Practice in Social Work Education Active, not recruiting
Mobile-Based Intervention to Promote Physical Activity Among the Elderly Active, not recruiting
Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents Recruiting

Other trials for the same condition

The "Quit-for-Kids" Project: to Increase Abstinence and Protect Children From Tobacco Smoke Exposure Recruiting
Metaphor-Based Smoking Cessation Intervention Starting soon
School-EduSmoke: A Cluster Randomized Controlled Trial for Promoting Smoking Cessation Among Parents of Schoolchildren Enrolling by invitation
Mobile-Based Intervention to Promote Physical Activity Among the Elderly Active, not recruiting
Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06570070 on ClinicalTrials.gov ↗ ← All trials in China